Avinger initiates full commercial launch of tigereye st image-guided cto crossing device

Redwood city, ca / accesswire / september 18, 2023 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced full commercial launch of its tigereye® st next generation image-guided chronic total occlusion (cto) crossing system. with the initiation of full commercial launch, all current and prospective accounts can now order the tigereye st device.
AVGR Ratings Summary
AVGR Quant Ranking